camptothecin has been researched along with lithium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asai, M; Kondo, Y; Miura, T; Sakamoto, T; Uchiyama, M | 1 |
| Beurel, E; Blivet-Van Eggelpoël, MJ; Cadoret, A; Capeau, J; Desbois-Mouthon, C; Kornprobst, M; Ruiz-Ruiz, C | 1 |
| Bryl, E; Jóźwik, A; Pietruczuk, K; Ruckemann-Dziurdzińska, K; Witkowski, JM | 1 |
3 other study(ies) available for camptothecin and lithium
| Article | Year |
|---|---|
Mesityllithium as a reagent for chemoselective halogen-lithium exchange reaction.
Topics: Camptothecin; Catalysis; Hydrocarbons, Halogenated; Lithium; Molecular Structure; Organometallic Compounds; Structure-Activity Relationship | 2001 |
GSK-3beta inhibition by lithium confers resistance to chemotherapy-induced apoptosis through the repression of CD95 (Fas/APO-1) expression.
Topics: Apoptosis; Camptothecin; Etoposide; fas Receptor; Gene Expression Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lithium; Promoter Regions, Genetic; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Suppressor Protein p53 | 2004 |
Cytoprotective effect of lithium against spontaneous and induced apoptosis of lymphoid cell line MOLT-4.
Topics: Antipsychotic Agents; Apoptosis; Camptothecin; Cell Line; Cytoprotection; DNA Damage; Humans; Lithium; Lymphocytes; Mitochondria | 2009 |